Tag Archives: HOW DOES MERCK’S COVID-19 PILL COMPARE TO PFIZER’S?

Pfizer and Merck have developed experimental antiviral pills that have shown promising efficacy in trials of adults with COVID-19 who are at high risk of serious illness. Both drugs also are being studied to see if they can prevent infection in people exposed to the virus. Here is an explanation of the differences in the two pills. Which of the …

Read More »